Research Currently Recruiting
Following is a list of research studies currently recruiting patients.
For more information or if you are interested in participating in any of the research studies below, please leave a voicemail for our research team at 206-320-2200.
CENSUM
A Phase 1 Randomized Study of MEDI-551 in Subjects with Relapsing-Remitting Multiple Sclerosis.
Sponsor: MedImmune, LLC
Type of MS: RR
Contact: Beena Gangadharan at 206-320-2633
IM22 ( Immunoglobulin)
A Double-Blind, Placebo Controlled, Single Ascending Intravenous Infusion Study of rHIgM22 in Patients with Multiple Sclerosis
Sponsor: Acorda Therapeutics
Types of MS: Any
Contact : Yuriko Courtney , Phone : (206) 320-2647
ARBACLOFEN
A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects with Spasticity due to Multiple Sclerosis
Sponsor: Xenoport
Type of MS: All types
Contact: Caryl Tongco 206-215-3565
Tcelna
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna™ in Subjects with Secondary Progressive Multiple Sclerosis
Sponsor: Opexa Therapeutics, Inc
Types of MS: SP
Contact : Yuriko Courntey , Phone : (206) 320 2647
More information
PRIME
A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter, Dose finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis
Sponsor: Avanir Pharmaceuticals
Types of MS: RR,SP
Contact : Beena Gangadharan , Phone : (206) 320 2633
Vitamin D
A randomized controlled trial of vitamin D in multiple sclerosis
Sponsor: John Hopkins University
Types of MS: RR
Contact : Caryl Tongco , Phone : (206) 215-3565
More Information
Wellness
Multiple Sclerosis Wellness Protocol
Sponsor: None
Types of MS: All types
MS EXACERBATION
Physical Therapy in Acute Motor MS Relapse
Sponsor: Swedish Foundation
Type of MS: RRMS
Contact: Colleen Ottinger at 206-320-3695
- RR = relapsing remitting, SP = secondary progressive, PP = primary progressive, CIS = clinicaly isolated syndrome
Contact Information
Multiple Sclerosis Center
1600 East JeffersonA Level
Seattle, WA 98122
Phone: 206-320-2200
Fax: 206-320-2560
Seattle Channel highlights Swedish MS Center research
Restoring cognition in multiple sclerosis
MS. Research Update: Birth month may affect your risk for MS
Dr. Bowen tackles mysteries of MS in Scientific American MIND
HelpLines Newsletter
Enlarge Text on this page
Scroll down to “enlarge text” on the bottom of the page, then click on the size you would like.


.jpg.aspx)

